Clinical Trials Logo

Spondylitis, Ankylosing clinical trials

View clinical trials related to Spondylitis, Ankylosing.

Filter by:

NCT ID: NCT06378697 Recruiting - Clinical trials for Ankylosing Spondylitis

A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis

Start date: November 10, 2023
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, multi-center phase III clinical study to evaluate the efficacy and safety of AK111 in the treatment of subjects with active ankylosing spondylitis.

NCT ID: NCT06369324 Recruiting - Clinical trials for Ankylosing Spondylitis

Efficacy of Pain Neuroscience Education and Physiotherapy in Patients Diagnosed With Spondyloarthritis

Start date: February 15, 2024
Phase: N/A
Study type: Interventional

Spondyloarthritis, notably ankylosing spondylitis (AS), represents a chronic rheumatic condition typified by persistent back pain and stiffness. It constitutes a substantial portion of diagnoses within rheumatology units and exhibits a higher prevalence among males. Diagnosis relies upon comprehensive clinical evaluation, including patient history, physical examination, and adjunctive radiological assessments, with genetic predisposition, particularly the presence of the HLA-B27 antigen, playing a significant role. Management strategies encompass a multidisciplinary approach, with physiotherapy emerging as a cornerstone therapeutic modality. Various exercise interventions, particularly those supervised by trained professionals, demonstrate efficacy in improving pain, stiffness, and overall functional capacity. Furthermore, patient education plays a pivotal role in enhancing treatment adherence and optimizing outcomes by aligning patient expectations with therapeutic goals. The evolving landscape of spondyloarthritis management underscores the necessity of further research into multimodal treatment approaches, particularly in integrating novel interventions such as electrophysical agents. By elucidating the mechanisms of action and exploring their synergistic effects, clinicians can refine treatment protocols and ultimately enhance the quality of care provided to individuals living with spondyloarthritis.

NCT ID: NCT06339957 Recruiting - Clinical trials for Rheumatoid Arthritis

Rheumatology Diet Study

Start date: March 1, 2024
Phase:
Study type: Observational

This study aims to collect information on rheumatology patients' dietary habits, autoimmune disease activity, dietary changes, disease symptom improvements, and perceptions on their dietary habits and how it affects their autoimmune disease. The main objective is to see if rheumatology patients change their dietary habits after their diagnosis of an autoimmune disease and if it subjectively improved their disease symptoms. It will also look at rheumatology patients' expectations for their rheumatologist when it comes to dietary advice and what resources they used to choose their new dietary habits. The study also seeks to measure the interest that rheumatology patients have in pursuing dietary changes as a means of controlling the symptoms of their autoimmune disease. It is expected that patients who changed their eating habits to healthier diets such as a Mediterranean diet would report less severe autoimmune disease symptoms. There are limited dietary recommendations for the management of many rheumatological diseases, so this study seeks to assess rheumatology patients' willingness to try dietary modifications, what improvements they had, and why they decide to make these changes in light of limited information.

NCT ID: NCT06287983 Recruiting - Clinical trials for Ankylosing Spondylitis

Effect of Inspiratory Muscle Training on Respiratory Functions and Exercise Capacity

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

In this study, we aimed to evaluate the effect of Anti- tumor necrosis factor (TNF) treatment on pulmonary functions in patients with AS and to evaluate the pulmonary functions and exercise performance of patients by adding inspiratory muscle training to spinal mobility exercises in patients with AS using Anti-TNF. We also aimed to investigate the relationship between these parameters and disease activity, spinal mobility and quality of life.

NCT ID: NCT06250062 Recruiting - Clinical trials for Ankylosing Spondylitis

A Clinical Study of JS005 in Patients With Ankylosing Spondylitis

Start date: January 12, 2024
Phase: Phase 2
Study type: Interventional

This is a multicentre, randomized, double-blind, parallel, placebo-controlled Phase II clinical study of 261 adults with active ankylosing spondylitis to evaluate the efficacy and safety of JS005 in the treatment of active ankylosing spondylitis.

NCT ID: NCT06242652 Not yet recruiting - Clinical trials for Ankylosing Spondylitis

A Study to Evaluate 608 in Patients With Ankylosing Spondylitis (AS)

Start date: March 19, 2024
Phase: Phase 2
Study type: Interventional

This study will evaluate the effect and safety of 608 in patients with AS.

NCT ID: NCT06226792 Completed - Clinical trials for Ankylosing Spondylitis

Muscle Architecture in Ankylosing Spondylitis

Start date: January 18, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to determine whether there is a decrease in muscle mass and the relationship between lower extremity skeletal muscle mass, muscle strength and disease activity in Ankylosing spondylitis. The main questions it aims to answer are: - Is there a relationship between the muscle thickness and pennation angle of the quadriceps, Gastrocnemius medialis and lateralis, Vastus medialis and lateralis and tibialis anterior muscles with disease activity and muscle strength? - Are there any differences in the results of morphological parameters of lower extremity muscles between Ankylosing spondylitis and voluntary participants? Researchers will compare voluntary participants to see if any difference in lower muscle morphological parameters.

NCT ID: NCT06198985 Not yet recruiting - Clinical trials for Ankylosing Spondylitis

The Effect of Dynamic Balance Exercises on Balance in Patients With Ankylosing Spondylitis.

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the effect of dynamic balance exercises added to current medical treatment on balance in patients with ankylosing spondylitis.

NCT ID: NCT06185712 Completed - Clinical trials for Ankylosing Spondylitis

Patient Education in Ankylosing Spondylitis

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

This study was carried out to investigate the effect of a nurse-led disease management education program in AS on patient compliance, disease activity, functional capacity, kinesiophobia, and quality of life. A total of 122 patients diagnosed with AS according to the modified New York criteria were included in the study. The intervention group received nurse-led individualized disease management education. In the control group, no interventions were performed other than routine clinical procedures.

NCT ID: NCT06138717 Recruiting - Clinical trials for Axial Spondyloarthritis and Ankylosing Spondylitis

The Effect of Aerobic Exercises and Yoga Exercises in Axial Spondyloarthritis

Start date: November 18, 2022
Phase: N/A
Study type: Interventional

Axial Spondyloarthritis (AxSpA), mainly affecting the axial skeleton and sacroiliac joints, is a chronic, systemic, inflammatory disease that causes structural and functional disorders. Exercise has a significant role to play in managing treatments. This study aimed to determine the effect of yoga-based exercises combined with aerobic exercise on spinal mobility, disease activity and aerobic capacity in AxSpA.